Assyro AI

Orange Book product · Brand (NDA)

COTEMPLA XR-ODT

METHYLPHENIDATE

Brand (NDA)NDA 205489TE ABRX NEOS THERAPS INC

At a glance

Jun 19, 2017

Approved

Brand (NDA)

Application

AB

TE code

4

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 19, 2017

    9 yr 2 mo ago

  2. Patent 8840924 expires

    Listed drug product patent expiration.

    Jun 05, 2026

    14 d ago

  3. Today

  4. Patent 9072680 expires

    Listed drug product patent expiration.

    Jun 28, 2032

    in 6 yr 1 mo

  5. Patent 9089496 expires

    Listed drug product patent expiration.

    Jun 28, 2032

    in 6 yr 1 mo

  6. Patent 11166947 expires

    Listed method-of-use patent (U-3299) expiration.

    Jan 25, 2038

    in 11 yr 9 mo

Pharmaceutical detail

Active ingredient

METHYLPHENIDATE

Strength

8.6MG

Dosage form

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE

Route

ORAL

TE code

AB

Application

NDA 205489

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8840924Jun 05, 202614 d ago
Product
9072680Jun 28, 2032in 6 yr 1 mo
Product
9089496Jun 28, 2032in 6 yr 1 mo
Product
11166947Jan 25, 2038in 11 yr 9 mo
U-3299
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.